Beacons of the Start-up Scene, part 5: MIR Insight
Tapping into Future-oriented Synergies of Data Analysis in the Materials Sector
Interview mit Bjol R. Frenkenberger, MIR Insight
Since its launch in 2019, the CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has provided more than 100 start-ups from over 15 countries with the opportunity to present their innovative ideas, products and technologies to a broad target group. We are taking this milestone as an opportunity to look back at some of the start-up stories of the past six years and highlight their development.
In this issue: MIR Insight. Founded in 2021 and based in Oslo, Norway, the company offers its customers data-driven forecasts created with the help of AI for accurate, dynamic demand forecasting. Co-founder and CEO Bjol R. Frenkenberger explainswhat has happened since its launch in December 2022 .
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
Company
MIR Insight ASGaustadalléen 21
0349 Oslo
Norway
most read

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0

Relocation of Chemicals Production Footprint in Full Swing
A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.

US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.

Pharma 4.0—the Key Enabler for Successful Digital Transformation in Pharma
Part 3: Seven Theses for successful Digitalization in Pharma









